The Trump administration is drawing a hard line when it comes to children and irreversible medical procedures.
On December 18, the U.S. Department of Health and Human Services announced proposed rules that would bar hospitals from performing sex-rejecting medical procedures on minors if they want to keep their Medicare or Medicaid funding.
And since almost every hospital in the country relies on those programs, this isn’t a small tweak. It’s a major shift.
The move follows an executive order from President Donald Trump directing federal agencies to step in and stop what his administration says are unsafe and unproven practices involving children.
What the Proposal Targets
At the center of the proposal are puberty blockers, cross-sex hormones, and surgeries performed on patients under 18.
Federal officials say these treatments can cause permanent harm and don’t meet accepted medical standards for children.
How the Rules Would Be Enforced
The enforcement would come through the Centers for Medicare and Medicaid Services.
CMS plans to update hospital participation rules so that facilities performing these procedures on minors could lose access to federal health care dollars.
CMS is also proposing a separate rule to block federal Medicaid funding for these procedures for children under 18. The same restriction would apply to the Children’s Health Insurance Program for patients under 19.
According to HHS, 27 states already don’t cover these treatments through Medicaid.
Permanent Changes, Important Questions
This isn’t a small decision. Treatments that can permanently affect fertility, bones, or brain development should come with clear proof that they work and that they’re safe.
HHS says that proof just isn’t there.
In a peer-reviewed review released last month, the agency found no reliable evidence that these treatments are safe or effective for children.
Despite that, claims data show nearly 14,000 minors received sex-rejecting procedures between 2019 and 2023.
The FDA Steps In
The Food and Drug Administration is also stepping in. The agency is sending warning letters to 12 companies accused of illegally marketing breast binders to children.
These devices are regulated medical products approved for limited uses, such as recovery after mastectomy, not for treating gender dysphoria in minors.
FDA Commissioner Marty Makary warned that enforcement could ramp up quickly, adding that seizures and injunctions could follow if the behavior continues.
Reversing a Biden-Era Policy
This isn’t the only change HHS is making.
The agency is also moving to roll back a Biden-era policy that tried to classify gender dysphoria as a disability under federal civil rights law.
Deputy Secretary Jim O’Neill said that approach pushed the law well beyond what it was meant to do.
“Our rule would restore regulatory clarity,” O’Neill said, and give health care providers room to set evidence-based policies without worrying they’re violating federal rules.
Nevada Is Not on the Sidelines
In Nevada, the proposal could have real consequences.
Hospitals in Clark and Washoe counties depend heavily on Medicare and Medicaid payments. Nevada’s Medicaid program covers hundreds of thousands of residents, including many children.
Federal standards matter here.
Critics Push Back
Critics say the administration is inserting government into private medical decisions and denying care to vulnerable youth. They argue families and doctors should decide what’s best.
Supporters respond with a simple question: If a child can’t legally vote, sign a contract, or buy a house, why should they be allowed to consent to medical treatments that permanently change their body?
What Comes Next
For now, these rules are still proposals. Public comments will be accepted before anything’s finalized.
But the direction is clear.
The administration is saying when it comes to children’s health, it’s going to err on the side of caution.
And it has no intention of using taxpayer dollars to back medical procedures it believes carry serious, permanent risks.
The opinions expressed by contributors are their own and do not necessarily represent the views of Nevada News & Views. Digital technology was used in the research, writing, and production of this article. Please verify information and consult additional sources as needed.
